Clinical Trials for Prostate Cancer
PHEN’s “Find Your Trial (FYT)” search tool connects patients with actively recruiting prostate cancer clinical trials that can possibly benefit them. The FYT tool has seven easy to use searchable categories to help patients find and review clinicals trials based on where they are on their prostate cancer journey. All trials listed have links to important information, including description, study locations, contacts and more.
All Trials
Find Your Trial
Omaha-004 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and whose cancer progressed on or after they were previously treated with next-generation Hormonal Agent (NHA). Study of Investigational Drug, MK5684, in...
PHEN’s Educational Resources Highlighted During Recent May Meeting
Newly diagnosed prostate cancer patients often don’t know where to start. That’s why PHEN’s Prostate Cancer Disparity Rally held in April emphasized patient educational resources to help men learn about early detection as well as better understand their treatment...
AMG 509 Patient Summary – Metastatic Castration Resistant
This clinical trial is for patients who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond to abiraterone acetate or enzalutamide (but not both) and to taxane-based chemotherapy. Study of AMG 509 in Subjects with Metastatic...
MK-5684-01A Patient Summary – Metastatic Castration Resistant
Background Information Metastatic castration-resistant prostate cancer (mCRPC) is a form of prostate cancer that keeps growing even when male hormones like testosterone are decreased to very low levels. Current treatments include drugs that block these hormones,...
Find Your Trial
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.